Duration of Chemotherapy and Neurotoxicity
1:41
YouTubeNEJM Group
Duration of Chemotherapy and Neurotoxicity
Six months of chemotherapy with oxaliplatin plus a fluoropyrimidine is standard in stage III #coloncancer, but oxaliplatin is associated with cumulative neurotoxicity. Would a shorter course be effective? Read the full study: https://nej.md/2pIwq5N
31.8K viewsMar 29, 2018
Oxaliplatin Side Effects
ctDNA-Guided Therapy in Stage II Colon Cancer | NEJM
1:57
ctDNA-Guided Therapy in Stage II Colon Cancer | NEJM
YouTubeNEJM Group
9.7K viewsJun 16, 2022
Cancer Drugs Shortage: America-Iran का दिखा असर, कैंसर मरीजों पर बड़ा संकट! इन दवाओं की सप्लाई ठप!
3:19
Cancer Drugs Shortage: America-Iran का दिखा असर, कैंसर मरीजों पर बड़ा संकट! इन दवाओं की सप्लाई ठप!
YouTubeNews Nation
287 views4 weeks ago
Personalized chemotherapy guided by ctDNA refines post-surgery colon cancer care
1:39
Personalized chemotherapy guided by ctDNA refines post-surgery colon cancer care
YouTubeAJE Video Bytes
20 views6 months ago
Top videos
Dr. Axel Grothey Examines the Use of Adjuvant Oxaliplatin in Colon Cancer
0:57
Dr. Axel Grothey Examines the Use of Adjuvant Oxaliplatin in Colon Cancer
YouTubeOncLive
1K viewsFeb 7, 2013
The STARGLO trial: glofitamab in combination with gemcitabine and oxaliplatin in R/R DLBCL
2:04
The STARGLO trial: glofitamab in combination with gemcitabine and oxaliplatin in R/R DLBCL
YouTubeVJHemOnc – Video Journal
605 viewsJun 20, 2024
Tailoring immunotherapy in lymphoma: selecting agents in the current landscape
2:20
Tailoring immunotherapy in lymphoma: selecting agents in the current landscape
YouTubeVJHemOnc – Video Journal
114 views1 month ago
Oxaliplatin Uses
Dr Enzinger on the Current Landscape of Biomarker Driven Approaches in Esophageal Cancer
1:21
Dr Enzinger on the Current Landscape of Biomarker Driven Approaches in Esophageal Cancer
YouTubeOncLive
40 views3 months ago
Bispecific antibodies in DLBCL: promising combinations & moving these agents into earlier lines
3:33
Bispecific antibodies in DLBCL: promising combinations & moving these agents into earlier lines
YouTubeVJHemOnc – Video Journal
67 views5 months ago
The CRS-RS.5p predictive model of CRS after glofitamab treatment in patients with R/R DLBCL
2:08
The CRS-RS.5p predictive model of CRS after glofitamab treatment in patients with R/R DLBCL
YouTubeVJHemOnc – Video Journal
36 views6 months ago
Dr. Axel Grothey Examines the Use of Adjuvant Oxaliplatin in Colon Cancer
0:57
Dr. Axel Grothey Examines the Use of Adjuvant Oxaliplatin in Colon Cancer
YouTubeOncLive1K viewsFeb 7, 2013
The STARGLO trial: glofitamab in combination with gemcitabine and oxaliplatin in R/R DLBCL
2:04
The STARGLO trial: glofitamab in combination with gemcitabine and oxaliplatin in R/R DLBCL
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc605 viewsJun 20, 2024
Tailoring immunotherapy in lymphoma: selecting agents in the current landscape
2:20
Tailoring immunotherapy in lymphoma: selecting agents in the current landscape
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc114 views1 month ago
ctDNA-Guided Therapy in Stage II Colon Cancer | NEJM
1:57
ctDNA-Guided Therapy in Stage II Colon Cancer | NEJM
YouTubeNEJM Group9.7K viewsJun 16, 2022
Cancer Drugs Shortage: America-Iran का दिखा असर, कैंसर मरीजों पर बड़ा संकट! इन दवाओं की सप्लाई ठप!
3:19
Cancer Drugs Shortage: America-Iran का दिखा असर, कैंसर मरीजों पर बड़ा संकट! इन दवाओं की सप्लाई ठप!
YouTubeNews Nation287 views4 weeks ago
Personalized chemotherapy guided by ctDNA refines post-surgery colon cancer care
1:39
Personalized chemotherapy guided by ctDNA refines post-surgery colon cancer care
YouTubeAJE Video Bytes20 views6 months ago
Dr Enzinger on the Current Landscape of Biomarker Driven Approaches in Esophageal Cancer
1:21
Dr Enzinger on the Current Landscape of Biomarker Driven Approaches in Esophageal Cancer
YouTubeOncLive40 views3 months ago
3:33
Bispecific antibodies in DLBCL: promising combinations & moving these agents into earlier lines
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc67 views5 months ago
2:08
The CRS-RS.5p predictive model of CRS after glofitamab treatment in patients with R/R DLBCL
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc36 views6 months ago
2:39
Using External Infusion Pumps Safely
YouTubeU.S. Food and Drug Administration78K viewsJul 7, 2010
1:06
Approaching the treatment of a patient with DLBCL who has relapsed following Glofit-GemOx
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc75 views1 year ago
2:35
Results of the Phase III POLARGO trial: POLA-R-GEMOX for the treatment of R/R DLBCL
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc79 viewsJul 17, 2025
1:29
STARGLO 2-year follow-up: durability of responses in patients with DLBCL receiving Glofitamab-GemOx
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc218 viewsJun 17, 2025
3:42
Warning Signs of Peripheral Neuropathy?
YouTubeCleveland Clinic137.6K viewsMay 2, 2025
2:28
POLA-R-GEMOX regimen is a promising option for relapsed/refractory diffuse large B-cell lymphoma
YouTubeecancer37 views10 months ago
4:55
Results from the Phase III POLARGO trial: Pola-R-GemOx vs R-GemOx for R/R DLBCL
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc142 viewsJul 1, 2025
1:46
The EPCORE NHL-2 trial: epcoritamab plus GemOx in transplant-ineligible R/R DLBCL
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc72 viewsJun 18, 2025
See more
Static thumbnail place holder